Free Newsletter
Top-ranked woman to retire from J&J
There's another big executive departure coming in the world of Big Pharma: this time it's Christine Poon (photo), vice chairman of Johnson & Johnson and worldwide chair of its pharmaceuticals division. Poon, 56, plans to retire on March 1, J&J announced today, saying that it will announce a succession plan "in a timely fashion."
With 20 years in pharma, 15 of them at Bristol-Myers Squibb before she joined J&J, Poon has been a heavyweight in the industry. She's the top-ranked woman in the drug business, and, according to Forbes, one of the most respected. The magazine ranked her as the 26th most powerful woman in business in 2006.
- see J&J's release
- read the Forbes article
- get more from Pharmalot
Related Article:
J&J reorg anoints growth czar
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: